Antares Pharma, Inc. Income Statement 2011-2024 | ATRS

Annual Income Statement Antares Pharma, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	727 M	768 M	487 M	353 M	341 M	180 M	305 M	604 M	419 M	242 M
Shares	166 M	203 M	163 M	156 M	155 M	147 M	131 M	127 M	110 M	97 M
Net Income	56.2 M	-2.03 M	-6.52 M	-16.7 M	-24.3 M	-20.7 M	-35.2 M	-20.5 M	-11.4 M	-4.39 M
Revenue	150 M	124 M	63.6 M	54.5 M	52.2 M	45.7 M	26.5 M	20.6 M	22.6 M	16.5 M
EBITDA	16.2 M	3.55 M	-13.9 M	-14.3 M	-22.3 M	-18.9 M	-33.9 M	-20.3 M	-11.2 M	-4.27 M
Operating Expenses	72.9 M	72.4 M	49.1 M	43.5 M	47.5 M	46.7 M	50.4 M	32.3 M	24.5 M	14.1 M
General and Administrative Expenses	62.8 M	61.8 M	36.8 M	30.4 M	26.4 M	26.9 M	31.7 M	8.29 M	7.2 M	5.85 M

All numbers in USD currency